Democratizing hedge fund level analysis tools for everyone
| Name | Royal Prima Tbk. |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Providers |
| Code | F1 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| Dr. I Nyoman Ehrich Lister | 71.72 | 71.72 |
| Public < 5% | 21.55 | 21.56 |
| Robin | 6.25 | 6.25 |
| Treasury Shares | 0.45 | 0.45 |
| Mok Siu Pen | 0.03 | 0.02 |
| Source | 2022 | 2021 |
|---|---|---|
| PRIM | F1 | RSU Royal Prima |
| PRIM | F1 | Rumah Sakit Marelan |
| PRIM | F1 | RS Royal Prima Jambi |
| PRIM | F1 | Others |
| PRIM | F1 | In-patient |
| PRIM | F1 | Out-patient |
| Region | 2022 | 2021 |
|---|---|---|
| PRIM | F1 | Indonesia |
| PRIM | F1 | Others |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 0.81 | # 3 / 22 |
| EV_EBITDA | 10.72 | # 6 / 22 |
| PER | -27.03 | --- / 22 |
| PBV | 0.29 | # 2 / 22 |
| DER | 0.12 | # 3 / 22 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | -3.016 | --- / 22 |
| ROA % | -0.9400000000000001 | --- / 22 |
| ROE % | -1.05 | --- / 22 |
| Year | DPS | Yield [%] |
|---|
| Timeframe | Performance |
|---|---|
| 1W % | -1.2 |
| 1Mo % | -8.0 |
| 3Mo % | 33.3 |
| 1Yr % | 29.0 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| SRAJ | -1,231.62 | 143.50 T | 147.48 T | 3,202 B | 469 B | -114 B |
| MIKA | 28.90 | 36.99 T | 36.33 T | 5,127 B | 1,945 B | 1,279 B |
| SILO | 27.25 | 24.91 T | 28.54 T | 12,210 B | 2,554 B | 914 B |
| HEAL | 51.37 | 23.05 T | 26.55 T | 6,777 B | 1,799 B | 450 B |
| PRAY | 64.86 | 11.03 T | 12.46 T | 2,201 B | 464 B | 170 B |
| CARE | 3,850.00 | 10.24 T | 10.66 T | 316 B | 79 B | 3 B |